标题
Development of at-line assay to monitor charge variants of MAbs during production
作者
关键词
-
出版物
BIOTECHNOLOGY PROGRESS
Volume 30, Issue 1, Pages 249-255
出版商
Wiley
发表日期
2013-12-21
DOI
10.1002/btpr.1848
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche
- (2014) C Main et al. HEALTH TECHNOLOGY ASSESSMENT
- Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
- (2014) J Ford et al. HEALTH TECHNOLOGY ASSESSMENT
- Systematic Review and Quality Assessment of Cost-Effectiveness Analysis of Pharmaceutical Therapies for Advanced Colorectal Cancer
- (2013) Henry WC Leung et al. ANNALS OF PHARMACOTHERAPY
- Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema
- (2013) Joshua D. Stein et al. OPHTHALMOLOGY
- What's fueling the biotech engine—2011 to 2012
- (2012) Saurabh Aggarwal NATURE BIOTECHNOLOGY
- At What Cost Does a Potential Survival Advantage of Bevacizumab Make Sense for the Primary Treatment of Ovarian Cancer? A Cost-Effectiveness Analysis
- (2011) David E. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Charge variants in IgG1
- (2010) Leslie A. Khawli et al. mAbs
- Characterization of a Monoclonal Antibody Cell Culture Production Process Using a Quality by Design Approach
- (2010) Brian Horvath et al. MOLECULAR BIOTECHNOLOGY
- Reduced elimination of IgG antibodies by engineering the variable region
- (2010) T. Igawa et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Glycosylation pattern of humanized IgG-like bispecific antibody produced by recombinant CHO cells
- (2009) Wook-Dong Kim et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- The Economic Value of Innovative Treatments over the Product Life Cycle: The Case of Targeted Trastuzumab Therapy for Breast Cancer
- (2009) Louis P. Garrison et al. VALUE IN HEALTH
- THE COST BURDEN OF TRASTUZUMAB AND BEVACIZUMAB THERAPY FOR SOLID TUMOURS IN CANADA
- (2008) Arik Drucker Current Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now